TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05681026

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga Sessions
Description: Participants will have up to 12 sessions, 3 sessions per week starting two weeks before the transplant and throughout the first 30 days of your hospitalization.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaries
Description: Participants will complete 4 questionnaires about any symptoms you may be having, any anxiety and/or depression you may be having, your quality of life, and your expectations about your treatment.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interviews
Description: Participants will have an exit interview last about 30-45 minutes. The interview will be conducted over the phone or remotely over Zoom, FaceTime, or other approved video call methods.). The interview will be audio and video recorded and transcribed (typed).
Study: NCT05521958

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Acute injury without compartment syndrome
Description: Acute tibial shaft or tibial plateau fractures who do not have clinical compartment syndrome.~Muscle punch biopsy of the anterior compartment will be taken.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Acute injury with compartment syndrome
Description: Acute tibial shaft or tibial plateau fractures who have clinical compartment syndrome.~Muscle punch biopsy of the anterior compartment will be taken.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Exertional compartment syndrome
Description: For patients with exertional compartment syndrome, a muscle biopsy will be obtained from affected extremity.
Study: NCT06567249

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intracoronary hypothermia
Description: This trial stands apart from other studies of intracoronary hypothermia, mainly because it will establish the role of intracoronary hypothermia in reducing infarct size not only in the left anterior descending artery territory but in other vessels as well, including the right coronary artery and circumflex coronary artery.

Intervention type: OTHER
Group type: OTHER
Intervention: Standard percutaneous coronary intervention
Description: Percutaneous coronary intervention is performed in a standard manner.
Study: NCT04800367

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romosozumab Prefilled Syringe [Evenity]
Description: 2 syringes of 105 MG/1.17 mL subcutaneous solution injected one after the other, once a month from study baseline through 11 month visit

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Denosumab 60 MG/ML Prefilled Syringe [Prolia]
Description: 1 subcutaneous injection of 60 mg/mL every six months from study 12 month visit through the 24 month visit. Injections occur at the 12 and 18 month visits.
Study: NCT05328167

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Perflutren Protein-Type A Microspheres
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Contrast-Enhanced Ultrasound
Description: Undergo CEUS
Study: NCT06588413

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olanzapine
Description: Subjects will be randomized to either olanzapine 2.5 mg or 5 mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Olanzapine
Description: Subjects will be randomized to either olanzapine 2.5 mg or 5 mg
Study: NCT06585943

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Forced Rate Exercise + Rehab
Description: The FE+rehab group (N=33) will complete FE on the cycle designed to augment pedaling rate to \>75 RPM. Target heart rate zone will be set to 60-80% of HR reserve. The session will consist of a 5-min warm-up, 35-min main exercise set, and 5-min cool down. Following FE, abbreviated sessions of motor learning-based training will be administered by a neurologic OT and PT experienced in stroke rehabilitation, with 30 min focused on restoration of UE function (OT) and 15 min focused on LE motor function/ gait training (PT).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation
Description: The rehab group will receive consecutive, full-length sessions of motor learning-based training, administered by a neurologic OT and PT experienced in stroke rehabilitation, with 45 min focused on restoration of UE function (OT) and 45 min focused on LE motor function/ gait training (PT).
Study: NCT06611033

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V118C
Description: Intramuscular Administration
Study: NCT05204524

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide for injection combined with epirubicin
Description: Temozolomide for injection, according to the requirements of GCP, the test drug should be sealed, kept away from light and kept at 2-8℃, with a valid period of 24 months.
Study: NCT04844281

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Precision1® Daily Disposable Toric Contact Lens
Description: Soft, toric contact lens used to correct distance vision and astigmatism.
Study: NCT06611033

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V118
Description: Intramuscular Administration

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PREVNAR 20™
Description: Intramuscular Administration

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Saline
Description: Intramuscular Administration

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Saline
Description: Intramuscular Administration
Study: NCT06081946

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Histamine
Description: Histaminergic itch will be evoked by a 1% histamine solution. A droplet of histamine solution will be placed on the predetermined area on the forearm, and the SPT lancet will be pierced through the histamine with 120 g of pressure for 1-2 seconds

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cowhage
Description: 25 spicules will be inserted in the centre of the predefined skin area on the mandibular area. The spicules will be gently rubbed for 15-20 seconds in circular motion to facilitate epidermal penetration
Study: NCT06612255

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delafloxacin
Description: Delafloxacin tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delafloxacin
Description: Delafloxacin tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delafloxacin Powder
Description: Delafloxacin powder for oral suspension formulation

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delafloxacin Powder
Description: Delafloxacin powder for oral suspension formulation

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delafloxacin Powder
Description: Delafloxacin powder for oral suspension formulation

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delafloxacin Powder
Description: Delafloxacin powder for oral suspension formulation
Study: NCT04662086

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acebilustat
Description: 100 mg capsule administered orally once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camostat
Description: 200 mg (2 x 100 mg tablet) administered orally four times daily (800 mg total daily dose).
Study: NCT05503914

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: low-dose radiotherapy
Description: On the first and second days of induction chemotherapy, local tumor were irradiated with 0.5Gy bid for 4 times.
Study: NCT06102707

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluzopril Combined With Apatinib
Description: Fluzopril Capsules 100mg po bid Apatinib Mesylate Tablets 250mg po qd
Study: NCT05887973

Intervention type: BEHAVIORAL
Intervention: The T.R.I.G.G.E.R Project
Description: The T.R.I.G.G.E.R Project includes the following core components to address root causes of gun violence:~* Summer Employment~* Social and Emotional Learning~* Future Orientation~* Adult and Peer Support~* Critical Consciousness~* Civic Efficacy and Engagement

Intervention type: BEHAVIORAL
Intervention: The T.R.I.G.G.E.R Project
Description: The T.R.I.G.G.E.R Project includes the following core components to address root causes of gun violence:~* Summer Employment~* Social and Emotional Learning~* Future Orientation~* Adult and Peer Support~* Critical Consciousness~* Civic Efficacy and Engagement

Intervention type: BEHAVIORAL
Intervention: The T.R.I.G.G.E.R Project
Description: The T.R.I.G.G.E.R Project includes the following core components to address root causes of gun violence:~* Summer Employment~* Social and Emotional Learning~* Future Orientation~* Adult and Peer Support~* Critical Consciousness~* Civic Efficacy and Engagement

Intervention type: BEHAVIORAL
Intervention: The T.R.I.G.G.E.R Project
Description: The T.R.I.G.G.E.R Project includes the following core components to address root causes of gun violence:~* Summer Employment~* Social and Emotional Learning~* Future Orientation~* Adult and Peer Support~* Critical Consciousness~* Civic Efficacy and Engagement
Study: NCT05089383

Intervention type: DRUG
Intervention: Utrogestan
Description: PROSPECTIVE STUDY

Intervention type: DRUG
Intervention: Utrogestan
Description: PROSPECTIVE STUDY
Study: NCT04997330

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active rTMS
Description: Bilateral high frequency (20Hz) rTMS will be delivered (over dorsolateral prefrontal cortex), at two daily sessions (left side on the morning and right side on the afternoon), 10 consecutive days on working day, 1500 pulses/session, 110% of motor threshold determined, 30 trains, 50 pulses per train and 15s inter train. A session will typically last around 10 minutes. Alcohol cues consisted of a selection of 60 alcohol-related pictures (beverage, drinking-related behaviors, alcohol-related cues) from the Geneva Appetitive alcohol Pictures will be presented during each rTMS session.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham rTMS
Description: Sham rTMS will be delivered (over dorsolateral prefrontal cortex) , at two daily sessions (left side on the morning and right side on the afternoon), 10 consecutive working days. A session will typically last around 10 minutes. Alcohol cues consisted of a selection of 60 alcohol-related pictures (beverage, drinking-related behaviors, alcohol-related cues) from the Geneva Appetitive alcohol Pictures will be presented during each rTMS session.
Study: NCT05221541

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: vibration
Description: whole-body vibration and soleus tendon vibration will be applied to participants
Study: NCT05889117

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst treatment (iTBS) using MagPro Transcranial Magnetic Stimulator (manufacturer: Magventure)
Description: 3-10 minute sessions of brain stimulation applied to the left dorsolateral prefrontal cortex, up to 10 sessions a day, 30 sessions in total, planned within 2 weeks.
Study: NCT04671511

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Targeted Axillary Dissection
Description: Sentinel Node Biopsy (SNB; using Tc99 +/- Blue dye) + Radioactive Seed Localisation (RSL) of clipped node using I125 seed = Targeted Axillary Dissection (TAD)

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasound of the axilla
Description: Prospectively recorded preoperative ultrasound of the axilla. Number of suspicious nodes recorded. Biopsy and clipping of the positive node.
Study: NCT05117606

Intervention type: DEVICE
Group type: OTHER
Intervention: LYNG by Ably Medical
Description: Comparing LYNG to traditional, standard equipment for heart rate, respiration, movement, and blood pressure.
Study: NCT04910100

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nebivolol Ophthalmic Suspension 1 Percent
Description: 1 drop instilled into each eye twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nebivolol Ophthalmic Suspension 0.5 Percent
Description: 1 drop instilled into each eye twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Timolol Ophthalmic Suspension 0.5 Percent
Description: 1 drop instilled into each eye twice daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Timolol Ophthalmic Solution 0.5 Percent
Description: 1 drop instilled into each eye twice daily
Study: NCT04924387

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise
Description: All patients will start learning how to activate the abdominal muscles in the first training session. The exercise progression will be adapted according to the capacity of each patient, considering their pain levels. The exercises will be made in 1 to 3 series of among 8 and 15 repetitions and the isometric contractions for 5 to 10 seconds. The rests between series will be of 30 seconds, and between exercises of 2-3 minutes.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: All patients will start learning how to activate the abdominal muscles in the first training session. The exercise progression will be adapted according to the capacity of each patient, considering their pain levels. The exercises will be made in 1 to 3 series of among 8 and 15 repetitions and the isometric contractions for 5 to 10 seconds. The rests between series will be of 30 seconds, and between exercises of 2-3 minutes.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: All patients will start learning how to activate the abdominal muscles in the first training session. The exercise progression will be adapted according to the capacity of each patient, considering their pain levels. The exercises will be made in 1 to 3 series of among 8 and 15 repetitions and the isometric contractions for 5 to 10 seconds. The rests between series will be of 30 seconds, and between exercises of 2-3 minutes.
Study: NCT04871776

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Messaging informed by construal level theory
Description: Messages are informed by construal level theory, which suggests that emphasizing why elicits more abstract thinking, or high-level construals, and can induce an emotional mindset, which could challenge an individual's sense of identity, autonomy, or political preferences. Conversely, emphasizing how is more cognitive and evokes concrete thinking, or low-level construals, and encourages a planning or implementation mindset, which may be better for encouraging vaccine uptake.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Messaging informed by construal level theory
Description: Messages are informed by construal level theory, which suggests that emphasizing why elicits more abstract thinking, or high-level construals, and can induce an emotional mindset, which could challenge an individual's sense of identity, autonomy, or political preferences. Conversely, emphasizing how is more cognitive and evokes concrete thinking, or low-level construals, and encourages a planning or implementation mindset, which may be better for encouraging vaccine uptake.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual messaging sent by Mass General Brigham
Study: NCT05946668

Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo vaginal specimen self-collection via vaginal swab collection kit

Intervention type: OTHER
Intervention: Electronic Health Record Review
Description: Medical records reviewed

Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete questionnaires
Study: NCT06247176

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sensory Habituation Protocol
Description: The first session continues with the Mock MRI, which lasts 10 minutes. Participant's comfort level in VR will be evaluated.~At the pre-exposure visit, participants complete an MRI scan on a 3 Tesla MRI, which takes approximately 1 hour \& 15 minutes. It consists of structural \& functional MRI scans. Structural scans require the participant to stay still with eyes closed. Functional scans will require the participant to lie with eyes closed or watch and listen to sensory stimulation.~VR exposure will occur across 3 1-hour sessions at most. Participants will be asked to complete a sensory habituation protocol, in which they will watch and listen to sensory stimuli in VR for an increasing amount of time. Between the sensory stimuli, the participant will watch a self-selected video.~Finally, the subject will be asked to do a post-exposure MRI visit, which is the same as the pre-exposure visit.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sensory Habituation Protocol
Description: The first session continues with the Mock MRI, which lasts 10 minutes. Participant's comfort level in VR will be evaluated.~At the pre-exposure visit, participants complete an MRI scan on a 3 Tesla MRI, which takes approximately 1 hour \& 15 minutes. It consists of structural \& functional MRI scans. Structural scans require the participant to stay still with eyes closed. Functional scans will require the participant to lie with eyes closed or watch and listen to sensory stimulation.~VR exposure will occur across 3 1-hour sessions at most. Participants will be asked to complete a sensory habituation protocol, in which they will watch and listen to sensory stimuli in VR for an increasing amount of time. Between the sensory stimuli, the participant will watch a self-selected video.~Finally, the subject will be asked to do a post-exposure MRI visit, which is the same as the pre-exposure visit.
Study: NCT06494735

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MyMCT
Description: Using the french version of the metagognitive bibliotherapy MyMCT
Study: NCT05875584

Intervention type: DIAGNOSTIC_TEST
Intervention: rbcDNA test
Description: fecal immunochemical test

Intervention type: DIAGNOSTIC_TEST
Intervention: rbcDNA test
Description: fecal immunochemical test
Study: NCT05101252

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: senofilcon A C3
Description: TEST Lens

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dailies Total 1 Multifocal Contact Lenses
Description: CONTROL Lens
Study: NCT05835726

Intervention type: DRUG
Intervention: Daratumumab
Description: NDMM (newly diagnosed multiple myeloma) who fulfill the inclusion criteria, candidate to stem cell mobilization, collection, and autologous stem cell transplant who receive a Daratumumab-containing induction regimen.
Study: NCT06418971

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CarePair
Description: This study will pilot test the feasibility and acceptability of a digital self-assessment and referral tool using machine learning models to enhance service use and address unmet needs in ADRD caregivers.
Study: NCT06141642

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Self-adaptive serious game
Description: A self-adaptive serious game in immersive virtual reality using the device MetaQuest 1 or 2

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Non-adaptive serious game
Description: A non-adaptive serious game in immersive virtual reality using the device MetaQuest 1 or 2
Study: NCT04534829

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fluoroscopic-guided Radiofrequency Ablation
Description: Radiofrequency ablation of the posterior SIJ complex under fluoroscopic-guidance

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Radiofrequency Ablation
Description: Radiofrequency ablation of the posterior SIJ complex under ultrasound-guidance
Study: NCT06119373

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single daily icodextrin exchange
Description: PD initiation with single daily exchange of 2-liter icodextrin-based dialysis solution.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional PD group
Description: PD is initiated with 2 to 3 exchanges of 2-liter glucose-based dialysis solution.
Study: NCT04745533

Intervention type: DIAGNOSTIC_TEST
Intervention: Antigen detection test
Description: To compare the results of the antigen detection test against the polymerase chain reaction in the study of contacts of COVID-19 patients during quarantine.
Study: NCT04982718

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: OraQuick® HCV Self-Test
Description: Self-testing will be performed using the OraQuick® HCV Self-Test manufactured by OraSure Technologies Inc., USA. Modified IFU developed by the manufacturer will be used to adapt the below professional use kits to a self-test: the OraQuick® HCV Rapid Antibody Test is prequalified by WHO and CE marked for professional use (sensitivity 98.1%, specificity 99.6%).~As it is not approved for self-test use in Malaysia, the OraQuick® HCV Self-Test kits provided to participants in the intervention group will be labelled for Research Use Only (RUO) and test results will not be used for patient management.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: First Response® HCV Self-Test
Description: Self-testing will be performed using the First Response® HCV Card Test (Self Test) manufactured by Premier Medical Corporation, India. Modified IFU developed by the manufacturer will be used to adapt the below professional use kits to a self-test: the First Response® HCV Card Test is CE-marked and currently under WHO review for professional use (sensitivity 100%, specificity 100%).~As it is not approved for self-test use in Malaysia, the First Response® HCV Self-Test kits provided to participants in the intervention group will be labelled for Research Use Only (RUO) and test results will not be used for patient management.
Study: NCT05225116

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Sintilimab will be at a dose of 200mg,Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: On the first day of the trial, Lenvatinib will be taken orally once daily （8mg/day ≤ 60kg or 12mg/day ≥60kg).

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: Radiotherapy will be completed within two weeks at a dose of 300cGy× 10 fraction
Study: NCT06535789

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inhaled Technosphere Insulin
Description: Patients will receive TI (Afrezza) to be compared to RAA following a breakfast meal
Study: NCT06537206

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Application Footbath
Description: The foot bath application for the experimental group will be applied with water at 38-40 degrees Celsius for an average of 10 minutes under thermometer control. Immediately afterward, the second physiological parameters will be measured.
Study: NCT06542471

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dual intramedullary nailing
Description: - Elastic nailing for radius under image guidance through distal entry point and physeal sparing technique.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dual plating
Description: - ORIF for radius done first through volar approach.
Study: NCT06541821

Intervention type: OTHER
Intervention: survey evaluation
Description: assessment of physical activity, fear of movement, and ostomy compliance

Intervention type: OTHER
Intervention: survey evaluation
Description: assessment of physical activity, fear of movement, and ostomy compliance